Alchemi creates AI software to speed up drug development.
Alchemi has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Alchemi's investors include Flybridge, Nebular, Maple VC.
Alchemi is headquartered in New York, United States.
Alchemi creates AI software to speed up drug development.
Alchemi is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alchemi — Funding & Investors." VCBacked, July 22, 2024, https://www.vcbacked.co/company/alchemi. Accessed July 19, 2026.
VCBacked. (2024). Alchemi — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/alchemi
{{cite web |title=Alchemi — Funding & Investors |url=https://www.vcbacked.co/company/alchemi |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated